Lisa Holt
Psychiatric/Mental Health · Mason City, IANPI 1013772714
Payments from drug & device makers
Across 108 payments — averaging $20.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$405
- Teva Pharmaceuticals USA, Inc.$318
- Otsuka America Pharmaceutical, Inc.$268
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$248
- Johnson & Johnson$247
- Lundbeck LLC$182
- plus $503 from 8 others
What the payments were for
- Food & beverage$2,06695%
- Education$1045%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 24 | $405 |
| Teva Pharmaceuticals USA, Inc. | 11 | $318 |
| Otsuka America Pharmaceutical, Inc. | 14 | $268 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 12 | $248 |
| Johnson & Johnson | 12 | $247 |
| Lundbeck LLC | 8 | $182 |
| Neurocrine Biosciences, Inc. | 7 | $132 |
| Axsome Therapeutics, Inc. | 5 | $97 |
| Vanda Pharmaceuticals Inc. | 4 | $90 |
| Indivior Inc. | 4 | $69 |
| Ironshore Pharmaceuticals Inc. | 2 | $35 |
| E.r. Squibb & Sons, L.L.C. | 2 | $35 |
| Collegium Pharmaceutical, Inc. | 2 | $30 |
| Alkermes, Inc. | 1 | $16 |
How this compares
$2,170 in reported general payments places this provider in the 70th percentile of 443 psychiatric/mental health providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aripiprazole | 23 | $239 |
| Quetiapine Fumarate | 14 | $228 |
| Risperidone | 14 | $180 |
| Fluoxetine Hcl | 18 | $124 |
| Buspirone Hcl | 12 | $61 |
| Trazodone Hcl | 15 | $54 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Mason City
- Andrea AndersonMason City$4K
- Tarrah HollidayAtlantic$421K
- Kelsie SwisherParkersburg$235K
- Jennifer BradleyCedar Rapids$66K
- Kama AusbornWaterloo$64K
- Quentin ChambersDes Moines$40K
- Tenaea JeppesonFort Dodge$38K
- Jennifer WittmanCoralville$25K
- Amy MorinCedar Rapids$24K
- Jenna BerendzenCedar Falls$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.